Mounjaro (tirzepatide) is a prescription-only medicine for weight management and type 2 diabetes. Most of its side effects are in the gut, most are mild, and most show up in the first few weeks and again briefly after each dose increase. Here is what to expect week by week, what the trials show longer term, and the warning signs that need a doctor, from the pharmacy team at Laois Pharmacy in Portlaoise.
In 30 seconds
- The very common side effects are nausea, diarrhoea, vomiting, constipation and stomach pain. For most people they are mild to moderate and settle.
- They peak in the first weeks and for a week or two after each dose increase. That is why the dose rises in 2.5mg steps, no sooner than every 4 weeks.
- In the main weight management trial, about 2 to 4 people in 100 stopped because of stomach side effects, against about 1 in 200 on placebo.
- Severe stomach pain that does not go away, signs of dehydration, gallstones or an allergic reaction need medical help straight away.
- Mounjaro is not used in pregnancy. Stop it at least 1 month before trying for a baby.
Weeks 1 to 4: the 2.5mg starting dose
Tirzepatide copies two gut hormones, GLP-1 and GIP. It tells your brain you are full and slows how quickly your stomach empties, which is why most side effects are digestive. Everyone starts on 2.5mg once a week for 4 weeks, a run-in dose that lets your body adjust. People most often notice nausea, especially after a large or fatty meal, feeling full very quickly, loose stools or constipation, burping, wind or heartburn, tiredness, and mild redness or itch where they inject. The leaflet says nausea, diarrhoea and vomiting are most common when first starting and decrease over time in most people.
The HSE advice for this stage: small regular meals, eat slowly, stop as soon as you feel full, fewer fried and fatty foods, water through the day, no fizzy drinks, and do not lie down straight after eating. Inject on the same day each week and change the spot each time.
Weeks 5 to 8: the first dose increase
After 4 weeks the dose goes up to 5mg. Expect the stomach side effects to flare for a week or two and then ease. In the trials nausea, vomiting and diarrhoea were higher during dose increases and fell over time. If a step is hard going, tell your prescriber. The HSE says staying on a lower dose for longer, or delaying the next increase, can help.
- Contraception. The NHS advises an extra barrier method, such as condoms, for 4 weeks after starting and for 4 weeks after each dose increase, because stomach upset and slower stomach emptying can affect how the pill is absorbed.
- Missed dose. Within 4 days, take it as soon as you remember. After 4 days, skip it and take the next one on your usual day. Never take two doses together.
Months 3 to 6: further steps and the first proper review
Further increases come in 2.5mg steps with at least 4 weeks on each dose. The maintenance doses are 5mg, 10mg and 15mg, and 15mg is the maximum. Things that tend to appear now rather than at the start:
- Hair loss. Listed as common (up to 1 in 10) in people treated for weight management. Tell your prescriber if it worries you.
- Dizziness and low blood pressure. Both common in the weight management trials. Stand up slowly, keep drinking water, and do not drive if you feel dizzy.
- Gallstones. Uncommon (up to 1 in 100), but losing weight quickly raises the chance. Severe tummy pain needs a doctor.
- Low blood sugar. Very common if you also take insulin or a sulfonylurea for diabetes. Your doctor may lower those doses. On its own, Mounjaro rarely causes it.
Around 6 months is when prescribers judge whether the medicine is doing enough. UK guidance (NICE) says that if less than 5% of starting weight has been lost after 6 months on the highest tolerated dose, the prescriber should decide whether to continue.
Six months to three years: the longer-term data
Mounjaro was licensed for weight management in 2023, so the longest evidence comes from trials. From the product information:
- Up to 176 weeks on treatment. In SURMOUNT-1, people with prediabetes stayed on treatment for up to 176 weeks, about 3 years and 4 months. By the end, 1.2% on tirzepatide had developed type 2 diabetes, against 12.6% on placebo. The side effects seen over that time were the same stomach effects seen early on.
- Stopping. In SURMOUNT-4, people switched to placebo after 36 weeks on Mounjaro regained a substantial amount of the weight they had lost, while those who stayed on kept losing. The medicine works while you take it. See what happens after goal weight.
- Stopping because of side effects. In the weight management trial, 1.9% on 5mg, 4.4% on 10mg and 4.1% on 15mg stopped permanently because of a stomach side effect, against 0.5% on placebo.
- Serious but uncommon. Acute pancreatitis is uncommon, up to 1 in 100. Severe allergic reactions are rare, up to 1 in 1,000.
You can report a suspected side effect to the HPRA, and we will help you do it.
When to get help straight away
- severe stomach pain that does not go away, sometimes spreading to your back, with or without vomiting (possible pancreatitis)
- severe tummy pain with fever or vomiting (possible gallstones or gallbladder inflammation)
- signs of dehydration after a lot of vomiting or diarrhoea: passing very little urine, dark urine, dizziness. Dehydration can harm your kidneys
- signs of a serious allergic reaction: breathing problems, rapid swelling of the lips, tongue or throat, a fast heartbeat. Call 112 or 999
- low blood sugar if you take insulin or a sulfonylurea: headache, drowsiness, weakness, dizziness, hunger, confusion, fast heartbeat, sweating
If you have diabetes with eye problems (retinopathy), report any change in your vision to your prescriber. If you are having an operation or a procedure under sedation, tell the team you use Mounjaro, because it slows stomach emptying.
Pregnancy, breastfeeding and alcohol
- Pregnancy. Not recommended. Use contraception while you take it. If you want to become pregnant, stop at least 1 month before trying, because the medicine stays in the body for a long time.
- Breastfeeding. The NHS says it is not used while breastfeeding. Tell your doctor.
- Pancreatitis in the past. Not studied in people with a history of pancreatitis, so it is used with caution.
- Alcohol. The NHS advice is to avoid it, because it makes nausea and vomiting worse.
- Only on prescription, only from a pharmacy. Pens sold on social media or by unregistered websites may be fake or wrongly dosed. The HSE and HPRA both warn against them.
For meal ideas while you adjust, read what to eat on Ozempic or Mounjaro. For how a prescription reaches us, Healthmail, collection and cold-chain delivery, see our Mounjaro Ireland guide.
Questions about side effects?
Message our pharmacy team on WhatsApp or give us a call. Private, no pressure, and we will tell you straight if it needs your doctor.
Mounjaro side effects: common questions
How long do Mounjaro side effects last?
For most people the stomach side effects are worst in the first few weeks and for a week or two after each dose increase, then settle. If they last longer, or stop you eating and drinking properly, talk to your prescriber.
Do the side effects come back with every dose increase?
They often flare for a short time after each 2.5mg step and then ease. Your prescriber can delay the next increase or go back a step if needed.
What are the long-term side effects of Mounjaro?
Trials have followed people for up to 176 weeks. The side effects over that time were mostly the same stomach effects seen early on. Uncommon risks include gallstones and pancreatitis. Weight tends to come back if treatment stops.
Does Mounjaro cause hair loss?
Hair loss is listed as a common side effect in people treated for weight management, meaning up to 1 in 10. Tell your prescriber if it worries you.
Can I drink alcohol on Mounjaro?
The NHS advises avoiding alcohol while using tirzepatide because it makes nausea and vomiting worse. If you take other diabetes medicines, it can also raise the risk of low blood sugar.
What should I do if I miss a dose?
If it is 4 days or less since the dose was due, inject as soon as you remember. If more than 4 days have passed, skip it and take the next dose on your usual day. Do not take two doses to catch up.
Sources
- European Medicines Agency, Mounjaro SmPC and package leaflet (sections 4.2, 4.4, 4.6, 4.8, 5.1). EMA product information (PDF); EMA overview.
- Mounjaro 2.5 mg/dose KwikPen, Irish SmPC. medicines.ie.
- HSE, Medicines to treat obesity. www2.hse.ie.
- NHS, Tirzepatide. nhs.uk.
- NICE, TA1026 Tirzepatide for managing overweight and obesity, recommendation 1.2. nice.org.uk.
- Health Products Regulatory Authority. hpra.ie.
General information for people in Ireland, not a substitute for advice about your own health. Always read the leaflet and talk to your prescriber or pharmacist.

